Please login to the form below

Not currently logged in
Email:
Password:

drug launch

This page shows the latest drug launch news and features for those working in and with pharma, biotech and healthcare.

AbbVie scores FDA approval for arthritis treatment upadacitinib

AbbVie scores FDA approval for arthritis treatment upadacitinib

Humira has been hit hard by the recent launch of biosimilars, with the drug experiencing rapid losses in Europe. ... However, the pharma company does not see these side effects posing a risk to sales of the drug, with suggestions that the risks are

Latest news

More from news
Approximately 1 fully matching, plus 190 partially matching documents found.

Latest Intelligence

  • Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019 Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019

    This year’s report additionally features insight from the new Cortellis Analytics – Drug Timeline &Success Rates module, an analytic that predicts the probability of launch and timeline to market for ongoing ... The company expects to launch the drug

  • Launch trends 2019 Launch trends 2019

    What are the big trends in pharma and biotech drug launches for 2019? ... Large companies entering competitive spaces are planning for increased launch budgets to compete and win.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Camurus is currently preparing to launch the drug in the first European markets as early as January, and expects ‘substantial’ sales of the treatment during 2019, although it will take three ... Compared with a similar treatment marketed by Indivior,

  • A catalyst for change A catalyst for change

    This was considered a significant step in the internationalisation of the Chinese drug approval process. ... If any application is filed to launch a drug or medical device in China for the first time, the applicant shall provide clinical trial data on

  • Positive disruption in business intelligence Positive disruption in business intelligence

    A drug launch strategy. We live in an exciting time of opportunity for pharmaceutical business intelligence professionals. ... The first years immediately after a drug launch can set the course for the product’s success over the following decade.

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

  • NDA Group appoints Alison McGregor as its principal consultant NDA Group appoints Alison McGregor as its principal consultant

    She joins the group following a new US office launch. Drug development consultancy, NDA Group, has appointed Alison McGregor as its principal consultant following the opening of its new US office

  • Medicines Discovery Catapult appoints CEO Medicines Discovery Catapult appoints CEO

    Chris' experience of leading companies operating in life sciences combined with his in-depth knowledge of drug discovery will be of tremendous value to the company.”. ... The Catapult will engage the UK's experienced drug discovery talent and help

  • Astellas promotes John Demaree Astellas promotes John Demaree

    Demaree was promoted from his position as executive director of oncology marketing, where he oversaw the launch of prostate cancer drug Xtandi (enzalutamide) and promotion of lung cancer therapy Tarceva (erlotinib).

  • Paolo Paoletti named as executive chairman of Kesios Paolo Paoletti named as executive chairman of Kesios

    Paoletti was formerly the first appointed president of GSK Oncology, where he was responsible for the overall oncology business within the firm and oversaw activities from early drug discovery through to ... clinical development, launch and life cycle

  • Purdue looks to Merck for new CEO Purdue looks to Merck for new CEO

    His previous roles include president of Merck US, during which time he helped to launch the hepatitis C drug Victrelis (boceprevir) and led the acquisition of ophthalmology company Inspire Pharmaceuticals.

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics